Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.
Wagner TM, Hirtenlehner K, Shen P, Moeslinger R, Muhr D, Fleischmann E, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Petru E, Ropp E, Langbauer G, Kubista E, Scheiner O, Underhill P, Mountain J, Stierer M, Zielinski C, Oefner P. Wagner TM, et al. Among authors: muhr d. Hum Mol Genet. 1999 Mar;8(3):413-23. doi: 10.1093/hmg/8.3.413. Hum Mol Genet. 1999. PMID: 9971877
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics.
Wagner TM, Möslinger RA, Muhr D, Langbauer G, Hirtenlehner K, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Ropp E, Kubista E, Amirimani B, Helbich T, Becherer A, Scheiner O, Breiteneder H, Borg A, Devilee P, Oefner P, Zielinski C. Wagner TM, et al. Among authors: muhr d. Int J Cancer. 1998 Jul 29;77(3):354-60. doi: 10.1002/(sici)1097-0215(19980729)77:3<354::aid-ijc8>3.0.co;2-n. Int J Cancer. 1998. PMID: 9663595
Contributions of ATM mutations to familial breast and ovarian cancer.
Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Davis RW, Wagner TM, Oefner PJ. Thorstenson YR, et al. Among authors: muhr d. Cancer Res. 2003 Jun 15;63(12):3325-33. Cancer Res. 2003. PMID: 12810666
Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group.
Kroiss R, Winkler V, Kalteis K, Bikas D, Rudas M, Tea M, Fuerhauser C, Muhr D, Cerny H, Glueck S, Petru E, Concin H, Kubista E, Oefner P, Wagner T; Austrian Hereditary Breast and Ovarian Cancer Group. Kroiss R, et al. Among authors: muhr d. J Cancer Res Clin Oncol. 2008 Oct;134(10):1113-21. doi: 10.1007/s00432-008-0383-5. Epub 2008 Apr 8. J Cancer Res Clin Oncol. 2008. PMID: 18392852
32 results